Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GAA | P10253 | 7/20 | 0.61 |
| ▸ | MGAM | O43451 | 5/20 | 0.61 |
| ▸ | SI | P14410 | 5/20 | 0.61 |
| ▸ | MGAM2 | Q2M2H8 | 5/20 | 0.61 |
| ▸ | MCL1 | Q07820 | 9/20 | 0.55 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.55 |
| ▸ | HPGD | P15428 | 4/20 | 0.55 |
| ▸ | HSD17B10 | Q99714 | 4/20 | 0.55 |
| ▸ | MAPT | P10636 | 3/20 | 0.55 |
| ▸ | ALOX15 | P16050 | 3/20 | 0.55 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.55 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.55 |
| ▸ | LMNA | P02545 | 2/20 | 0.55 |
| ▸ | CYP1A2 | P05177 | 2/20 | 0.55 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.55 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.55 |
| ▸ | EGFR | P00533 | 1/20 | 0.55 |
| ▸ | PRKCG | P05129 | 1/20 | 0.55 |
| ▸ | PRKCB | P05771 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29363321 | 1.00 | GAA (0.61) | GAAMGAMSIMGAM2MCL1 | |
| SCHEMBL27739742 | 0.83 | GAA (0.53) | GAAMGAMSIMGAM2MCL1 | |
| SCHEMBL15288853 | 0.78 | GPR35 (0.41) | GAAMGAMSIMGAM2KDM4E | |
| SCHEMBL4658019 | 0.77 | GAA (0.75) | GAAMGAMSIMGAM2MCL1 | |
| SCHEMBL8571050 | 0.75 | MET (0.51) | GAAMGAMSIMGAM2MCL1 | |
| SCHEMBL15842620 | 0.75 | MCL1 (0.48) | GAAMGAMSIMGAM2MCL1 | |
| SCHEMBL8571187 | 0.73 | GAA (0.53) | GAAMGAMSIMGAM2MCL1 | |
| SCHEMBL12814095 | 0.73 | CA9 (0.72) | GAAMGAMSIMGAM2MCL1 | |
| SCHEMBL17696461 | 0.72 | HSD17B3 (0.42) | GAAMCL1KDM4EALDH1A1HPGD | |
| Daphnetin SCHEMBL29612544 | 0.71 | MCL1 (1.00) | GAAMGAMSIMGAM2MCL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 145 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260010026-A1 | ENGINEERED LIQUID CRYSTAL SHUTTER AS A DYNAMIC LONG-PASS OPTICAL FILTER | BLAZE BIOSCIENCE INC (US) | 2026-01-08 | — | — | US | claimed |
| WO-2024011209-A2 | ENGINEERED LIQUID CRYSTAL SHUTTER AS A DYNAMIC LONG-PASS OPTICAL FILTER | Blaze Bioscience, Inc. (US) | 2024-01-11 | — | — | WO | claimed |
| EP-4172600-A1 | SYSTEMS AND METHODS FOR SIMULTANEOUS NEAR-INFRARED LIGHT AND VISIBLE LIGHT IMAGING | Blaze Bioscience, Inc. (US) | 2023-05-03 | — | — | EP | claimed |
| CN-116034301-A | System and method for simultaneous near infrared and visible imaging | 光明之火生物科学公司 | 2023-04-28 | — | — | CN | claimed |
| US-20220346650-A1 | SYSTEMS AND METHODS FOR VASCULAR AND STRUCTURAL IMAGING | BLAZE BIOSCIENCE INC (US) | 2022-11-03 | — | — | US | claimed |
| EP-4037553-A1 | SYSTEMS AND METHODS FOR VASCULAR AND STRUCTURAL IMAGING | Blaze Bioscience, Inc. (US) | 2022-08-10 | — | — | EP | claimed |
| WO-2021263159-A1 | SYSTEMS AND METHODS FOR SIMULTANEOUS NEAR-INFRARED LIGHT AND VISIBLE LIGHT IMAGING | Blaze Bioscience, Inc. (US) | 2021-12-30 | — | — | WO | claimed |
| WO-2021067563-A1 | SYSTEMS AND METHODS FOR VASCULAR AND STRUCTURAL IMAGING | Blaze Bioscience, Inc. (US) | 2021-04-08 | — | — | WO | claimed |
| EP-3773137-A1 | SYSTEMS AND METHODS FOR SIMULTANEOUS NEAR-INFRARED LIGHT AND VISIBLE LIGHT IMAGING | Blaze Bioscience, Inc. (US) | 2021-02-17 | — | — | EP | claimed |
| US-20210015350-A1 | SYSTEMS AND METHODS FOR SIMULTANEOUS NEAR-INFRARED LIGHT AND VISIBLE LIGHT IMAGING | Blaze Bioscience, Inc. (US) | 2021-01-21 | — | — | US | claimed |
| WO-2019191497-A1 | SYSTEMS AND METHODS FOR SIMULTANEOUS NEAR-INFRARED LIGHT AND VISIBLE LIGHT IMAGING | Blaze Bioscience, Inc. (US) | 2019-10-03 | — | — | WO | claimed |
| WO-2017032487-A1 | PROTEASOME INHIBITOR COMPRISING A SIGNAL-EMITTING MOIETY | Technische Universität München (DE) | 2017-03-02 | — | — | WO | claimed |
| CN-104303059-B | Method for detecting intracellular infectious agents in sperm cells | 瓦西利奥斯·齐列瓦可斯 | 2016-08-17 | — | — | CN | claimed |
| US-20150204885-A1 | METHOD FOR THE DIRECT DETECTION OF MYCOBACTERIUM TUBERCULOSIS | TSILIVAKOS, VASSILIOS (GR) | 2015-07-23 | — | — | US | claimed |
| EP-2882861-A2 | METHOD FOR THE DIRECT DETECTION OF MYCOBACTERIUM TUBERCULOSIS | Poulakis, Nicolaos (GR) | 2015-06-17 | — | — | EP | claimed |
| US-20150064691-A1 | METHOD OF INTRACELLULAR INFECTIOUS AGENT DETECTION IN SPERM CELLS | TSILIVAKOS VASSILIOS (GR) | 2015-03-05 | — | — | US | claimed |
| EP-2831588-A1 | METHOD OF INTRACELLULAR INFECTIOUS AGENT DETECTION IN SPERM CELLS | Tsilivakos, Vassilios (GR) | 2015-02-04 | — | — | EP | claimed |
| WO-2014023984-A2 | METHOD FOR THE DIRECT DETECTION OF MYCOBACTERIUM TUBERCULOSIS | POULAKIS NICOLAOS (GR) | 2014-02-13 | — | — | WO | claimed |
| WO-2013144662-A1 | METHOD OF INTRACELLULAR INFECTIOUS AGENT DETECTION IN SPERM CELLS | TSILIVAKOS VASSILIOS (GR) | 2013-10-03 | — | — | WO | claimed |
| WO-2009064366-A2 | METHODS AND COMPOSITIONS FOR PROTEIN LABELING USING LIPOIC ACID LIGASES | MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) | 2009-05-22 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260010026-A1 | ENGINEERED LIQUID CRYSTAL SHUTTER AS A DYNAMIC LONG-PASS OPTICAL FILTER | CRYZ, TRPC3, TRPC1 | GAA 4782/4885MGAM 2966/4885SI 3721/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.